Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Arthritis care & research

Volumn 62, Issue 12, 2010, Pages 1787-1795

  Terrier, B ^a   Launay, D ^b   Kaplanski, G ^b   Hot, A ^b   Larroche, C ^b   Cathebras P ^b   Combe, B ^b   de Jaureguiberry, J P ^b   Meyer, O ^b   Schaeverbeke, T ^b   Somogyi, A ^b   Tricot, L ^b   Zenone T ^b   Ravaud, P ^b   Gottenberg, J E ^b   Mariette, X ^b   Cacoub, P ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL TRIAL; COMPARATIVE STUDY; CRYOGLOBULINEMIA; DOSE RESPONSE; FEMALE; FOLLOW UP; FRANCE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; REGISTER; TREATMENT OUTCOME; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; AUTOIMMUNITY; CRYOGLOBULINEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME; VASCULITIS;

MLCS; MLOWN;

EID: 79952115984     PISSN: None     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20318     Document Type: Article

References (0)